Simulations Plus Inc.

Simulations Plus Inc.

SLP

Get informed when a big investor buys or sells

+ Follow
Market Cap$374.16M
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Simulations Plus Inc.Simulations Plus Inc.45.1-6%4.6-
$18.50

Target Price by Analysts

0% upsideSimulations Plus Target Price DetailsTarget Price
$22.02

Current Fair Value

19% upside

Undervalued by 19% based on the discounted cash flow analysis.

Share Statistics

Market cap$374.16 Million
Enterprise Value$344.86 Million
Dividend Yield$- (-)
Earnings per Share$-3.22
Beta1.32
Outstanding Shares20,170,000

Return

Return on Equity5.83%ROE
Return on Assets5.30%
Return on Invested Capital-46.36%

Valuation & Multiples

P/E Ratio45.14P/E Ratio
PEG-42.87PEG
Price to Sales4.63Price to Sales
Price to Book Ratio3.08Price to Book Ratio
Enterprise Value to Revenue4.2
Enterprise Value to EBIT-5.34
Enterprise Value to Net Income42
Total Debt to Enterprise0.02
Debt to Equity0.04Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
July 13, 2026
EPS Estimate
$0.23
Average shareholder expectation
Revenue Estimate
$20.92 M
Average shareholder expectation

Next Earnings Call

Expected Date
October 28, 2026
EPS Estimate
$0.11
Average shareholder expectation
Revenue Estimate
$17.59 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.00000%
Total Calls-▼ 100.00%
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.11%▼ 79.36%
Total Invested$427,055▼ 99.85%
Investors Holding6▼ 165.00%

ESG Score

No data

About Simulations Plus Inc.

108 employees

Simulations Plus, Inc., is a leading provider of modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions. With its subsidiaries, Cognigen, DILIsym Services, and...